Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Dermata Therapeutics, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Dermata Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing treatments for dermatological and connective tissue diseases. The company's lead program targets medical and aesthetic skin conditions using novel small molecule therapeutics. Dermata is developing treatments for conditions including psoriasis, acne, rosacea, and keloid scarring. The company utilizes its proprietary understanding of skin biology and inflammation pathways to develop differentiated therapies. Dermata's pipeline includes both prescription pharmaceutical candidates and potential over-the-counter products.